Domenico Galetta

@giampygiampygi Ma per favore, Bastoni ha fatto una cretinata ma gli juventini, proprio loro, non devono parlare perché sono storicamente medaglia d’oro della specialità

Bastoni é l'emblema dell'antisportività. Rappresenta la cultura del vincere barando. Non rappresenta il calcio italiano e non deve mai più essere convocato in nazionale #bastoni #BastoniOUTNazionale #BASTONIOUT #InterJuventus #ladri

@isliquidbiopsy @UmbertoMalapel1 @ElJanLe It would be revolutionary if confirmed

In a prospective ES-SCLC cohort (n=20), DLL3 scoring on CTCs separated patients into DLL3Pos vs DLL3Low—and strongly tracked tarlatamab benefit: DLL3Pos had 100% clinical benefit, while DLL3Low rarely responded. #LiquidBiopsy #CTC #SCLC #ISLB @UmbertoMalapel1 @ElJanLe @drgandara @MJOSESERRANO19 @ChristianRolfo @DrYukselUrun @ErulEnes @ReduzziCarol @RobertoBoreaMD @ddemiguelperez @PasqualePisapia @Al3ssandroRusso @ESaldanhaMD @eleonora_nicolo @DrMirallas

We are proud to have you here in Bari as prestigious guests.

@Alfdoc2 @StephenVLiu @NReguart @marialuciareale @JessicaMenis @g_mountzios @Giangidegennaro Thanks @Alfdoc2

@StephenVLiu @galetta2 @NReguart @marialuciareale @JessicaMenis @g_mountzios @Giangidegennaro beautiful pics, fantastic place (love puglia) and fab people..the perfect mix

Celebrating time together at the IX Conferenza Oncologia Polmonare faculty dinner in Bari with @galetta2 @NReguart @marialuciareale @JessicaMenis @g_mountzios @Giangidegennaro

@StephenVLiu @NReguart @marialuciareale @JessicaMenis @g_mountzios @Giangidegennaro Thank you so much for your friendly and high-level scientific participation. It was an honor to host you in Bari.

Dr. Tina Cascone with the Keynote Presentation of Day 1 at the IX Conferenza Oncologia Polmonare. Neoadjuvant and perioperative immunotherapy has made a massive impact on resectable NSCLC with more to come. A major paradigm shift - now need new combinations and biomarkers.

La nostra avventura ad #AIOM si è conclusa con il progetto #ATLAS: ✅ Piattaforma #atlante BiomarkerAtlas; ✅ È un progetto scientifico; ✅ Dal 2024 è una #fondazione 🙏🏼Grazie ai fondatori e a tutti i ricercatori con #ATLAS danno luce e speranza al futuro della ricerca ✨

@ElJanLe @UmbertoMalapel1 @UmbertoMalapel1's main reason for strength and endurance is that he cannot be duplicated

📍2025-2029 ISLB President ⁦@UmbertoMalapel1⁩ and Vice President ⁦@ElJanLe⁩ in the Closing Ceremony - Orlando Congress. A lot of work to do to prepare educational activities, workshops, guidelines and our next congress in Madrid 2026.

@ChristianRolfo @UmbertoMalapel1 @isliquidbiopsy Congratulations to both of you. Two beautiful minds, two friends! Good luck!

Serving as @isliquidbiopsy ISLB President for the past 4 years has been a true honor. Now, I proudly pass the torch to my friend and inspiring leader, @UmbertoMalapel1 Thank you to all ISLB members for your trust and support—let’s continue advancing our mission together!

9,000 oncologists attending the ESMO plenary… and they’re all vibing with joy to be there. (Okay, maybe it’s an AI-generated video — but the enthusiasm is real!) #ESMO2025 #Oncology #AIhumor #PlenaryVibes

find the error #Esmo25 #smokefree

The young teacher (on the left) and the old student (to be guessed)

@StephenVLiu @isla_dolores @MARIANOPROVENCI @JordiRemon @tactics_md we are recruiting well and confidently

Wonderful discussions on early stage NSCLC with Dr. Tina Cascone. Interesting ongoing vaccine trials with V940 (mRNA + pembro post surgery). Dynamic discussion with experts @isla_dolores @MARIANOPROVENCI Joaquin Bosch @JordiRemon and Edurne Arriola touching on MPR and biomarkers

Final Presidential Plenary session at #WCLC25 chaired by Drs. @IsaOpitz @DrJNaidoo

The future, the talent and the awareness that I am a little elderly. A beautiful presentation of @PrelajArsela at #WCLC25

Great #WCLC25 opening Ceremony with the amazing chairs @UmbertoMalapel1 @DrJNaidoo @NReguart @IsaOpitz !! Congrats on the success of this excellent meeting! @IASLC

I'm sure it will be a unique experience once again

@n8pennell will it be the same without patients?

After 17 years at the Cleveland Clinic, I’m starting today as Senior Vice President and Worldwide Head of Hematology Oncology Medical Affairs at Bristol-Myers Squibb. I’m deeply grateful to my colleagues and patients at the Clinic for my experiences there. In my new role, I aim to help bring life-changing drugs to more people affected by cancer worldwide.

@StephenVLiu @LungCaJournal do we need another EGFR Tki?

First-in-human study of FHND-9041, novel 3G #EGFR TKI @LungCaJournal. Phase I in EGFR T790M NSCLC (n=87) established 80mg daily dosing. Phase II as 1L therapy (n=37): RR 62.2%, PFS 15.5m, leukopenia 23%, diarrhea 22%, G3/4 AEs: leukopenia (11%), LFTs (5%) lungcancerjournal.info/article/S0169-…